Skip to content

PDL BioPharma, Inc.

CIK 0000882104

← back to feed
Revenue (TTM)
$13.07M
−57.4% YoY FY Jan 2021
Net Income (TTM)
−$95.08M
+108.8% YoY FY Jan 2021
EPS Diluted (TTM)
−$0.81
+109.3% YoY FY Jan 2021
Gross Margin
12.9%
FY Jan 2021
Operating Margin
-515.2%
FY Jan 2021
Net Margin
-727.4%
FY Jan 2021
Free Cash Flow (TTM)
$127.22M
FY Jan 2021
Cash
$126.84M
FY Jan 2021
Total Debt
$19.21M
FY Jan 2021
Shares Outstanding
114.52M sh
FY Jan 2021

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings